Skip to Content
Home
|
Sitemap
|
Contact DCTD
Search this site
Home
Current Research
Funding Opportunities
Funding Announcements
Grantsmanship Resources
Partnerships
Scientific Advances
DCTD Research Findings
Drug Development Primer
Drugs Developed with DTP Involvement
Selected Drugs Developed with CTEP Involvement
Research Resources
Biomarkers
Biometric Research
Cancer Diagnosis Research
Clinical Proteogenomics
Clinical Trials
Drug Discovery and Development
Imaging
Radiation Research
News & Events
DCTD Meetings
DCTD Newsletter
2023 News
2022 News
2021 News
2020 News
2019 News
News Archive
About
Overview
Research Interests
DCTD Management
DCTD Research Grants
Staff Roster
Clinical Pharmacodynamic Biomarker Assays
NCLN-Supported Assays
PI3K/AKT signaling
MEK/ERK signaling
Apoptosis
DNA Damage Response
Additional Supported Assays
Epithelial-Mesenchymal Transition
MET
Poly(ADP-Ribose)
Historical Assays
Sample Collection SOPs
Frozen Biopsy Collection SOP – PADIS, FNLCR
Frozen Biopsy Collection SOP – EET Biobank
Streck Tube Collection SOP
DCTD Programs
Biometric Research Program
Cancer Diagnosis Program
Cancer Imaging Program
Cancer Therapy Evaluation Program
Developmental Therapeutics Program
Radiation Research Program
Translational Research Program
Office of Cancer Clinical Proteomics Research
Office of Cancer Complementary and Alternative Medicine
FOLLOW DCTD
Research Resources
|
Biomarkers
Last Updated: 08/21/2020
Sample Collection SOPs
Please email any questions or comments to
PDinfo@mail.nih.gov
.
NCI/NIH Resources
NIH Research Resources
NCI-Wide Research Resources
Early Detection
Research Network
NCI Community Oncology Research Program (NCORP)
NCI Mouse Repository
NCI COVID-19 Resources
DCTD Programs
Biometric Research Program
Cancer Diagnosis Program
Cancer Imaging Program
Cancer Therapy Evaluation Program
Developmental Therapeutics Program
Radiation Research Program
Translational Research Program
Office of Cancer Clinical Proteomics Research
Office of Cancer Complementary and Alternative Medicine
FOLLOW DCTD
FOLLOW DCTD